Find Your Board CEU Requirements & Accreditations:
Return to Course List

Schizophrenia - Diagnosis, Management, and Treatment

Author: Abimbola Farinde, PhD., PharmD

CE: 2 hours Pharmacology: 0.5 hour
Rated 4.7 out of 5.0 based on 3984 reviews

Course Summary

Schizophrenia can be regarded as a chronic, life-long condition. A patient suspected to suffer from schizophrenia requires a proper diagnosis and treatment plan if the patient is expected to maintain a reasonable quality of life. An understanding of the signs and symptoms of this disorder can aid with appropriate diagnosis and minimize delay in treatment. A diagnosis of schizophrenia can be made using the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Treatment options that can be available for the management of symptoms of schizophrenia can include typical and atypical antipsychotics that target the symptoms and provide effective management of the disorder. The use of these medications are widely recognized for the management of schizophrenia symptoms. An understanding of the mechanisms of action between antipsychotics can  affect the outcome of individual patients.

Course Format


Course Syllabus

I.      Introduction
II.     Defining Schizophrenia
1.      Pathophysiology
2.      Course of Illness
3.      Risk factors
4.      Subtypes of Schizophrenia
a)     Paranoid
b)     Disorganized (hebephrenic)
c)     Catatonic
d)     Undifferentiated
e)     Residual
5.      DSM-5 Diagnostic Criteria for Schizophrenia
6.      First-generation Antipsychotics
7.      Side Effects of First-generation Antipsychotics
8.      Initiation and Duration of Therapy
9.      Second-generation Antipsychotics
a)       Clozapine (Clozaril®)
b)       Risperidone (Risperdal®)
c)       Paliperidone (Invega®)
d)       Olanzapine (Zyprexa®)
e)       Quetiapine (Seroquel®)
f)        Ziprasidone (Geodon®)
g)       Aripiprazole (Abilify®)
10.    Newer Atypical Antipsychotic Agents
a)       Asenapine (Saphris®)
b)       Iloperidone(Fanapt®)
c)       Lursidone (Latuda®)
d)       Cariprazine (Vraylar®)
e)       Brexpiprazole (Rexulti®)
f)        Lumateperone (Caplytai®)
g)       Pimavanserin (Nuplazid®)
III.      Treatment Guidelines
IV.      Case Study: Schizophrenia and Antipsychotic Treatment
V.       Summary


Most of our courses will satisfy your CEU requirements. However, you can double check by using the search option at the top of this page.
You can download all the required materials above where it says "Preview the material"
No prerequisites are required for this course.
Yes. Once you read the material and complete the evaluation you can print your certificate right away from your "My Account" page.

How it Works


1. Confirm Your


2. Read the


4. Print Your